🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested
Primary Objective: To demonstrate sufficiency of the vaccine seroresponse ...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2019-10-04
Trial ID
NCT04142242
This is a multicenter, randomized, double-blinded, positive controlled stud...
Status
Completed
Location
Husada Utama Hospital
Start Date
2024-03-20
Trial ID
NCT06131554
This is a multicenter, randomized, observer-blinded, controlled, immune equ...
Status
Completed
Location
Lingga Health Research Center
Start Date
2020-02-04
Trial ID
NCT04204096
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Unknown
Location
Hunan Center for Disease Control and Prevention
Start Date
2021-12-10
Trial ID
NCT06314685
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923